Team
Mark L. Baum
President and CEO, Shrink Nanotechnologies, Inc.
Mark L. Baum, Esq. has more than 15 years experience financing, operating and advising public and private enterprises. Through Black Forest International and Noctua Fund, two funds he founded and co-manages, he has completed more than 200 rounds of financing. Mr. Baum has actively participated in public company spin-offs, restructurings and recapitalizations, venture fundings, reverse/forward mergers and multi-million dollar asset acquisitions and divestitures. Recently, Mr. Baum co-founded FIGA.org, an international expert network advisory service. Mr. Baum has a history of Boards of Directors and Boards of Advisors service. Mr. Baum capitalized the Mark L. Baum Scholarship Awards, funding tuition grants to students at UT Arlington. He is a trustee of the Collier de Bleu Trust, which funds education grants for children in Mexico. Mr. Baum is a published inventor and a licensed attorney.
James B. Panther, II
Chairman of the Board of Directors, Shrink Nanotechnologies, Inc.
James B. Panther II is the Chairman of the Board of Directors for Shrink Nanotechnologies. He currently is responsible for the day to day investment decision for Noctua Fund, LP. He brings significant experience in managing fund raising, financing, M & A, and advisory services in a merchant banking environment. Mr. Panther has raised, funded and participated in more than five hundred million dollars of debt and equity financing for private and publicly traded companies. As Managing Partner of Bristol Partners he was responsible for portfolio investments, leading over 20 transactions ranging from $15 million to $300 million in valuation and building a team of professionals that closed over 40 transactions. Mr. Panther holds B.A. in Finance from Boston College and a Degree in Economics from the University of Granada, Granada, Spain. He is fluent in English and Spanish.
Heiner Dreismann, PhD
Director, Shrink Nanotechnologies, Inc.
Heiner Dreismann, Ph.D. is an international executive with more than 24 years experience in the biotech and healthcare industries. Dr. Dreismann served as the President and CEO of Roche Molecular Systems, Inc., from 2000-2006, leading a staff of more than 1,600 and growing the RMS molecular IVD business from $640M to $1.2B in annual sales. Prior to serving as the senior executive at Roche Molecular Systems, Inc., Dr. Dreismann served as the Head of Global Business Development at Roche Diagnostics, responsible for business development for the Roche Diagnostics $7B IVD business. Dr. Dreismann’s post-doctoral fellowship was earned at the French Center for Nuclear Research in Saclay (near Paris). He earned his Masters Degree Diploma in Biology from Westfaelische Wilhelms University, Muenster, a Ph.D. in Microbiology/Molecular Biology from Westfaelische Wilhelms University, Muenster (summa cum laude).
Marshall Khine
Director, Shrink Nanotechnologies
Marshall Khine is an Assistant District Attorney for the San Francisco District Attorney’s Office. For the past four years, Mr. Khine has served on the Homicide Trial Team prosecuting murder cases. He has been a trial lawyer for over ten years with extensive experience in many areas of complex litigation. He graduated from Cornell University in Ithaca, New York in 1994. He attended California Western School of Law in San Diego, California on a full academic scholarship and graduated early with honors in 1997. While in law school and after law school, he worked for the In-house Legal Department of Cubic Corporation in San Diego. Since 1998, Mr. Khine has resided in the San Francisco Bay Area.
Michelle Khine, PhD
Scientific Research and Development, Founder Assistant Professor
Michelle Khine, PhD is the scientific founder of the Shrink nano-technology platform and a veteran entrepreneur, with a successful venture-capitalist (Series B) backed company Fluxion Biosciences located in San Francisco. She is a widely published researcher, with multiple patents grants and honors. Dr. Khine is on several review committees, most notably the Center for Scientific Review at the National Institute of Health. She is Assistant Professor of Bioengineering. Dr. Khine holds PhD, M.S. and B.S. degrees from the University of California Berkeley.
Sayantani Ghosh, PhD
Scientific Research and Development Assistant Professor
Sayatani Ghosh, PhD is an Assistant Professor and has performed significant research and is published in the fields of spintronics, liquid crystal quantum dot ensembles, plasmonics, and photovoltaics. Dr. Ghosh holds MS and PhD degrees from the University of Chicago, USA; a BA degree from the University of Cambridge, UK; and a BS degree from St. Stephen’s College, India.
Fabian Pease, PhD
Scientific Advisory Board Chairman Professor of Electrical Engineering, Stanford University
Fabian Pease, PhD is Professor of Electrical Engineering at Stanford University where his group’s areas of research include micro- and nano-fabrication and their application to electronic and magnetic devices and structures. Dr. Pease conducted research on the synthesis of DNA microarrays at Affymetrix Corporation and initiated programs in Advanced Microelectronics and Molecular-Level Printing the Defense Advanced Research Projects Agency. He has served as a consultant to IBM, Xerox, Etec Systems, and Lawrence Livermore Labs and is on the Technical Advisory Boards of Ultratech Stepper, San Jose, CA and Affymetrix, Santa Clara, CA. He has published over 200 articles and authored several book chapters. Dr. Pease holds BA, MA, and PhD degrees from Cambridge University, United Kingdom.
David D. Awschalom, PhD
Professor of Electrical and Computer Engineering, University of California Santa Barbara
David D. Awschalom, PhD is Professor of Physics and Electrical and Computer Engineering at the University of California-Santa Barbara. His research activities include optical and magnetic interactions in semiconductor quantum structures, spin dynamics and coherence in condensed matter systems, macroscopic quantum phenomena in nanometer-scale magnets, and implementations of quantum information processing in the solid state. He is a Fellow of the American Physical Society, the American Association for the Advancement of Science, the American Academy of Arts and Sciences, and a member of the National Academy of Sciences. Dr. Awschalom holds a B.Sc. in physics from the University of Illinois at Urbana-Champaign, and his Ph.D. in experimental physics from Cornell University.
Kara McCloskey, PhD
Scientific Advisory Board Member Assistant Professor
Kara McCloskey, PhD is Professor at School of Engineering, Universiy of California, Merced. She has conducted significant research in the field of tissue engineering with a specific focus on the cardiovascular system and stem cells. Professor McCloskey received a BS and an MS from Ohio State University and a PhD from Cleveland Clinic Foundation, conferred by Ohio State University.
Raveendran Pottathil, PhD
Scientific Advisory Board
Raveendran Pottathil, PhD is a biotechnology industry veteran. He has served as President, Vice President and Director at a number of biotechnology companies and as a section manager at Roche, overseeing the development of diagnostics, retroviruses, and DNA probes. He has authored 42 publications and has given numerous talks. Dr. Pottathil recieved a BS from the University of Kerala, India; an MS and PhD from the Cancer Research Institute, University of Bombay; and a Postdoctoral Fellowship at the Jackson Laboratory and Duke University.
Andrew Isaacs
Adjunct Professor of Entreprenuership, Haas School of Business, University of California Berkeley
Andrew Isaacs is Adjunct Professor of Entreprenuership at the Haas School of Business, University of California, Berkeley. Mr. Isaacs is involved in numerous directorships and is the President of California Technology Intl, Inc. He has served as Vice President of Kevex Instruments, and Senior Scientist at NASA Johnson Space Center. As an educator, he has guided many start up companies to sucess. Mr. Isaacs holds B.S. and M.S. degrees the University of Michigan.
Bruce R. Conklin, MD
Scientific Advisory Board
Professor
Bruce R. Conklin, MD, is a Senior Investigator at the Gladstone Institute of Cardiovascular Disease and a Professor at the University of California, San Francisco, with appointments in the Departments of Medicine and Cellular and Molecular Pharmacology. His research combines genetic techniques and bioinformatics to study G-Protein Couple Receptor hormone signaling involved in murine embryonic stem cells (mESC) and pluripotent embryonic stem (ES) cells. The cell lines can be used in to analyze toxic side effects of pharmaceuticals and study the differentiation of embryonic stem cells into cardiac tissues. Dr. Conklin served as the founding director of the Gladstone Genomics Core and is currently the founding director of the Gladstone Stem Cell Core. From 1995 to 2001, Dr. Conklin was the Associate Director of the General Clinical Research Center at San Francisco General Hospital. He is a member of several honorary societies including the American Society for Clinical Investigation. Dr. Conklin was the co-chair of the UCSF public science project in 1994, and is co-chair of the UCSF-California Academy of Sciences Affiliation Task Force. Dr. Conklin is the Associate Director of the Gladstone CIRM Scholars Training Program, and the recipient of a CIRM New Stem Cell Lines grant. Dr. Conklin is a key advisor to iPierian, Inc., a Kleiner Perkins-backed biopharmaceutical company located in San Francisco.
